Enhanced therapeutic effects for human pancreatic cancer by application K-ras and IGF-IR antisense oligodeoxynucleotides

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 33

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

228

HTML

2123

Figures (1-7)

126

Tables (1-1)

112

Sum=2589

Sep 7, 2008 (publication date) through Apr 22, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Research

World J Gastroenterol. Sep 7, 2008; 14(33): 5176-5185
Published online Sep 7, 2008. doi: 10.3748/wjg.14.5176

Table 1 Protein expression for K-ras and IGF-IR on Patu8988 cells detected by flow cytometry (%)

All values are presented as mean ± SD of triplicate determinations.

^bP < 0.01 vs control group.

Citation: Shen YM, Yang XC, Yang C, Shen JK. Enhanced therapeutic effects for human pancreatic cancer by application K-ras and IGF-IR antisense oligodeoxynucleotides. World J Gastroenterol 2008; 14(33): 5176-5185
URL: https://www.wjgnet.com/1007-9327/full/v14/i33/5176.htm
DOI: https://dx.doi.org/10.3748/wjg.14.5176